(Q31399123)

2 July 2017

title

Loratadine versus cetirizine: assessment of somnolence and motivation during the workday (English)

1 reference

2 July 2017

1 reference

Salmun LM

1

1 reference

2 July 2017

Gates D

2

1 reference

2 July 2017

Scharf M

3

1 reference

2 July 2017

Greiding L

4

1 reference

2 July 2017

Ramon F

5

1 reference

2 July 2017

Heithoff K

6

1 reference

2 July 2017

publication date

1 May 2000

1 reference

2 July 2017

published in

Clinical Therapeutics

1 reference

2 July 2017

volume

22

1 reference

2 July 2017

issue

5

1 reference

2 July 2017

page(s)

573-582

1 reference

A longitudinal study of respiratory symptoms in a community population sample. Correlations with smoking, allergen skin-test reactivity, and serum IgE

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Correlation between plasma diphenhydramine level and sedative and antihistamine effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Loss of work productivity due to illness and medical treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Involvement of histamine in the control of the waking state

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

The pharmacology and use of H1-receptor-antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Second-generation antihistamines: a comparative review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Pharmacokinetics and dose proportionality of loratadine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Loratadine: multiple-dose pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Studies on the central effects of the H1-antagonist, loratadine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

The influence of antihistamines on human performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

A Comparison of Central and Peripheral Effects of Cetirizine and Loratadine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

Variations among non-sedating antihistamines: are there real differences?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980045-4

7 January 2021

10.1016/S0149-2918(00)80045-4

Identifiers

DOI

1 reference

2 July 2017

1 reference